BCS Wealth Management’s Cardinal Health CAH Stock Holding History

BCS Wealth Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,215	Closed	-$204K	–	253
2025 Q2	$204K	Buy	+1,215	New	+$180K	0.04%	251

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BCS Wealth Management's CAH Position: Q3 2025 in Review

BCS Wealth Management sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 1,215 shares — an estimated $204K sold.

BCS Wealth Management first reported a position in CAH in Q2 2025 and held it in 1 quarter. The position peaked at $204K in Q2 2025. 1,225 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

BCS Wealth Management reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
BCS Wealth Management sold 1,215 Cardinal Health shares in Q3 2025, an estimated $204K.
BCS Wealth Management first reported a position in Cardinal Health in Q2 2025 and held it in 1 quarter.
BCS Wealth Management's Cardinal Health position peaked at $204K in Q2 2025.
1,225 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on BCS Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.